Yixuan Zou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIMS Congenital hyperinsulinism (HI) is the most common cause of persistent hypoglycaemia in infants and children. Exendin-(9-39), an inverse glucagon-like peptide 1 (GLP-1) agonist, is a novel therapeutic agent for HI that has demonstrated glucose-raising effect. We reported the first population pharmacokinetic (PopPK) model of the exendin-(9-39) in(More)
Experience with 13 free lateral thigh flaps is presented. In only one case was there necrosis and this was partial. The method of raising the flap is described in detail and the advantages and disadvantages are described. This flap is more difficult to raise than the medial thigh flap and care must be taken in searching for its supplying vascular pedicle.
  • 1